Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the details of meetings to be held with Analysts/Institutional investors. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the details of meetings to be held with Analysts/Institutional investors. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Update on Cancellation of Conference Call for Analysts and Investors Syngene International Ltd - 539268 - Trading Plan Under The SEBI (Prohibition Of Insider Trading Regulations, 2015
Pursuant to Regulation 5 of the SEBl (Prohibition of Insider Trading) Regulations, 2015, we hereby notify the enclosed trading plan formulated by Mr. Kenneth Barr, Senior Vice-President - Discovery Services. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the details of meetings to be held with Analysts/Institutional investors. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the details of meetings to be held with Analysts/Institutional investors. Syngene International Ltd - 539268 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Biocon Ltd & Others
Syngene International sees 4 crore shares sold in block deal, Biocon likely seller
As of December end, Biocon held 64.5 percent promoter stake in Syngene International. After the block deal, this will go down to 54.5 percent. Syngene International Ltd - 539268 - Intimation Regarding The Transfer Of Hyderabad Operations Of The Company To Syngene Scientific Solutions Limited, Wholly Owned Subsidiary.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, this is to inform you that the Company has entered into a Business Transfer Agreement on January 30, 2023 to transfer the operations of the Company in Hyderabad under slump sale arrangement to Syngene Scientific Solutions Limited ("SSSL"), a Wholly owned subsidiary of the Company with effect from April 1, 2023. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), please find the link for the transcript of the Q3 FY23 Earnings Call conducted on January 24, 2023 and uploaded on the website of the Company on January 30, 2023